INmune Bio Inc. announced the presentation of data on the use of INB03 in the treatment of high-risk MUC4 expressing HER2 at the San Antonio Breast Cancer Symposium.
AI Assistant
INMUNE BIO INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.